[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74346]], camposKey:1474-0338 2023-01-01 Hydroxychloroquine safety in Covid-19 vs non-Covid-19 patients: analysis of differences and potential interactions7179, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75102]], camposKey:0785-3890 2022-12-31 Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study379392, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78268]], camposKey:1137-4802 2022-01-01 El papel de la filosofía en el análisis (y la síntesis) del cine7393, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=74348]], camposKey:2072-6643 2022-01-01 Haplotypes in the GC, CYP2R1 and CYP24A1 Genes and Biomarkers of Bone Mineral Metabolism in Older Adults00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66755]], camposKey:2045-2322 2021-10-07 A multicenter case-control study of the effect of e-nos VNTR polymorphism on upper gastrointestinal hemorrhage in NSAID users00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66521]], camposKey:0946-1965 2021-04-01 Hydrochlorothiazide use and risk of non-melanoma skin cancer in Spain: A case/non-case study280288, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66522]], camposKey:0001-7310 2021-02-01 RF - Thiazide Diuretics and Nonmelanoma Skin Cancer FR- Tiazidas y cáncer cutáneo no melanoma176177, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56635]], camposKey:2047-9956 2021-01-01 A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use8893, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56695]], camposKey:2210-7703 2020-01-01 Bullous pemphigoid associated with the use of dipeptidil peptidase-4 inhibitors: analysis from studies based on pharmacovigilance databases713720, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56637]], camposKey:1663-9812 2020-01-01 Corrigendum: Influence of Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study (Frontiers in Pharmacology, (2020), 11, 10.3389/fphar.2020.00860)00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56816]], camposKey:1668-0227 2020-01-01 El cine como modelo de realidad: análisis de ¿Él¿ (Luis Buñuel, 1953)135150, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56611]], camposKey:0300-2896 2020-01-01 Hydroxychloroquine and Potential Drug Interactions in Older Adults La hidroxicloroquina y las posibles interacciones farmacológicas en ancianos00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=54298]], camposKey:0926-9959 2020-01-01 Kaposi sarcoma in patients on tumour necrosis factor alpha inhibitors: a case-noncase study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56636]], camposKey:1663-9812 2020-01-01 Polymorphisms Involved in Platelet Activation and Inflammatory Response on Aspirin-Related Upper Gastrointestinal Bleeding: A Case-Control Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56634]], camposKey:0091-2700 2019-01-01 Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: A Meta-analysis of Observational Studies5573, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56633]], camposKey:0767-3981 2019-01-01 Gastrointestinal safety of coxibs: systematic review and meta-analysis of observational studies on selective inhibitors of cyclo-oxygenase 2134147, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56817]], camposKey:0214-3429 2019-01-01 Guillain-Barré syndrome and influenza vaccines: current evidence. Síndrome de Guillain-Barré y vacuna antigripal: evidencia actual288295, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56811]], camposKey:1130-6343 2019-01-01 Medicamentos sujetos a seguimiento adicional en la Unión Europea1923, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41163]], camposKey:1130-6343 2019-01-01 Medicines under additional monitoring in the European Union Medicamentos sujetos a seguimiento adicional en la Unión Europea1923, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56638]], camposKey:0961-7671 2019-01-01 What can we learn from the public's understanding of drug information and safety? A population survey96104, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59303]], camposKey:0031-6970 2018-11-01 Only full adherence to proton pump inhibitors protects against drug-induced upper gastrointestinal bleeding15031511, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41160]], camposKey:0946-1965 2018-01-01 A polypharmacy risk prediction model for elderly patients based on sociodemographic and clinical factors577584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41161]], camposKey:0165-1781 2018-01-01 Antipsychotics and cardiovascular risk: A case/non-case study341347, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40832]], camposKey:2210-7703 2018-01-01 Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study928935, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=41162]], camposKey:1742-7835 2018-01-01 MEDICINES UNDER ADDITIONAL MONITORING: CRITERIA FOR INCLUSION, DISPENSATION CONDITIONS AND SAFETY6767, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56639]], camposKey:0094-6176 2018-01-01 New Anticoagulant Agents: Incidence of Adverse Drug Reactions and New Signals Thereof196204, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56757]], camposKey:0114-5916 2017-01-01 Atypical Fracture of the Sternum After Long-Term Alendronate Plus Cholecalciferol Treatment: A Case Report00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56814]], camposKey:1885-365X 2017-01-01 Conocimiento, política y lenguaje: un análisis contrapolítico5165, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3369]], camposKey:0025-7753 2017-01-01 Medication errors associated with oral administration of methotrexate. Data from spontaneous reporting and medical literature review Errores de medicación asociados a la administración oral de metotrexato. Datos de notificación espontánea y revisión de la bibliografía médica330332, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39773]], camposKey:0268-1315 2017-01-01 Risk excess of mortality and use of antipsychotics: a case-noncase study15, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3368]], camposKey:0264-410X 2017-01-01 Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations48704876, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56818]], camposKey:1137-4802 2017-01-01 Rubens en la República de Platón: ética frente a moral en la experiencia estética933, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=32]], camposKey:0114-5916 2016-01-01 Agranulocytosis Around the World10231023, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3370]], camposKey:1932-6203 2016-01-01 Carpal tunnel syndrome associated with oral bisphosphonates. A population-based cohort study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56810]], camposKey:1137-4802 2016-01-01 El origen de la música y su relación con lo óntico materno2946, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37]], camposKey:0033-3506 2016-01-01 Impact of regulatory measures on antipsychotics drug consumption in Castilla y Leon, Spain113119, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56819]], camposKey:1668-0227 2016-01-01 ¿Qué queremos decir cuando decimos ¿imagen¿? Una aproximación desde la teoría de las funciones del lenguaje137155, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3371]], camposKey:1053-8569 2015-01-01 Emergency contraceptive pill safety profile. Comparison of the results of a follow-up study to those coming from spontaneous reporting9397, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=35]], camposKey:0264-410X 2015-01-01 Guillain-Barre syndrome and influenza vaccines: A meta-analysis37733778, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56812]], camposKey:0985-5939 2015-01-01 Ideología y poética en Blancanieves (2012) de Pablo Berger413443, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56787]], camposKey:1137-4802 2015-01-01 Lo óntico y lo ontológico en "Melancholia" de Lars von Trier734, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40043]], camposKey:1742-7835 2014-01-01 Facial paralysis and vaccines. A case non-case approach in vigibase and in vaers1616, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56786]], camposKey:1137-4802 2014-01-01 La fantasía como reencuentro con lo real en el cine de Méliès00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40045]], camposKey:0114-5916 2013-01-01 Adverse Events Associated with Emergency Contraceptive: Comparing the Results of a Follow Up Study with Those Coming from Spontaneous Reporting874874, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39]], camposKey:0031-6970 2013-01-01 Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study559564, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40044]], camposKey:1742-7835 2013-01-01 Polypharmacy in highly dependent elderly patients: a series from Medora's electronical medical redords3030, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9199]], camposKey:1742-7835 2013-01-01 Weight Gain and Antipsychotics. A Case/non-case approach in vigibase88, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56679]], camposKey:0378-6080 2012-01-01 Antipsychotic drugs5184, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56789]], camposKey:1137-4802 2012-01-01 De la ideología a la política: la izquierda lacaniana4974, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40046]], camposKey:1053-8569 2012-01-01 Dementia Mortality Rates and Cholinesterase Inhibitors Consumption in Castilla y Leon (Spain). An Ecologic Study7474, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9192]], camposKey:1742-7835 2012-01-01 Hypnotics and mortality: a systematic review of literature3535, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56788]], camposKey:1137-4802 2012-01-01 La violencia y lo simbólico. Análisis de The Quiet Man725, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56795]], camposKey:1137-4802 2012-01-01 Lenguaje y conocimiento10, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=31]], camposKey:1742-7835 2012-01-01 METAMIZOL-INDUCED AGRANULOCYTOSIS: A CASE/NON-CASE STUDY OF SUSPECTED ADVERSE DRUG REACTIONS IN VIGIBASE3636, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30]], camposKey:1742-7835 2012-01-01 MUSCULOSKELETAL SYMPTOMS ASSOCIATED WITH BISPHOSPHONATES. A RETROSPECTIVE FOLLOW-UP STUDY WITH INFORMATION FROM THE HEALTH IMPROVEMENT NETWORK (THIN)3536, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3372]], camposKey:1053-8569 2012-01-01 Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): Changes in the consumption pattern following the introduction of extended release methylphenidate435441, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9204]], camposKey:1053-8569 2012-01-01 Weight Gain Associated with Antipsychotics in a Naturalistic Setting: Icaro Study443443, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=38]], camposKey:0264-410X 2011-01-01 Adverse events associated with pandemic influenza vaccines: Comparison of the results of a follow-up study with those coming from spontaneous reporting519522, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3373]], camposKey:0378-6080 2011-01-01 Antipsychotic drugs89123, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40048]], camposKey:1053-8569 2011-01-01 Carpal Tunnel Syndrome Associated with Bisphosphonates. A Population-Based Cohort Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56822]], camposKey:0124-1494 2011-01-01 El cine como experiencia estética615, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9195]], camposKey:0114-5916 2011-01-01 Hepatotoxicity Associated with Agomelatine: A Case/Non-Case Study969970, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=33]], camposKey:1742-7835 2011-01-01 Hip fracture rates and bisphosphonate consumption in Spain. An ecologic study3940, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=9197]], camposKey:0114-5916 2011-01-01 Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Meta-Analysis944945, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3374]], camposKey:0378-6080 2010-01-01 Antipsychotic drugs83122, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3377]], camposKey:0009-9236 2010-01-01 Response to rupatadine and heart rhythm disturbances3738, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3376]], camposKey:1139-7357 2010-01-01 Study about antibiotic therapeutic compliance in pharmacy offices Estudio sobre cumplimiento terapéutico de antibióticos en oficinas de farmacia247250, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3375]], camposKey:1053-8569 2010-01-01 Trends in the consumption of antidepressants in Castilla y León (Spain). Association between suicide rates and antidepressant drug consumption895900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=51830]], camposKey:0378-6080 2009-01-01 Antipsychotic drugs65104, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3378]], camposKey:1756-1833 2009-01-01 Drug Point: Strontium ranelate may cause alopecia12101210, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56790]], camposKey:1137-4802 2009-01-01 El Toro de la Vega: fiesta e ideología942, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12143]], camposKey:0210-6523 2009-01-01 Estudio en oficinas de farmacia: Grado de conocimiento y aceptación de EFG en pacientes y/o usuarios de oficina de farmacia213225, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12145]], camposKey:0210-6523 2009-01-01 Evolución del consumo de psicofármacos en Castilla y León durante el período 1992-2005161175, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40]], camposKey:0009-9236 2009-01-01 Heart Rhythm Disturbances Associated With Rupatadine: A Case Series From the Spanish and Portuguese Pharmacovigilance Systems481484, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3379]], camposKey:0378-6080 2008-01-01 Antipsychotic drugs5677, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56794]], camposKey:1137-4802 2008-01-01 El hecho fotográfico: imágenes del Holocausto928, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3381]], camposKey:0378-6080 2007-01-01 Antipsychotic drugs6086, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=12117]], camposKey:1137-4802 2007-01-01 El lenguaje y el mundo. Consideraciones en torno al relativismo1530, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3380]], camposKey:0114-5916 2007-01-01 Gynaecomastia associated with proton pump inhibitors: A case series from the Spanish pharmacovigilance system527531, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=34]], camposKey:1742-7835 2006-01-01 Hepatic damage related to non-steroidal anti-inflammatory drugs. A case/non case study3333, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39772]], camposKey:0114-5916 2006-01-01 HMG CoA reductase inhibitors and impotence - Two case series from the Spanish and French drug monitoring systems143149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56801]], camposKey:1137-4802 2006-01-01 La representación y el horror99122, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56804]], camposKey:1137-4802 2006-01-01 Matrimonio, fiestas y lazo social1532, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=36]], camposKey:1742-7835 2006-01-01 New antidepressant drugs and upper gastrointestinal bleeding. A case-control study2323, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40039]], camposKey:0767-3981 2006-01-01 Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems391395, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3382]], camposKey:0378-6080 2005-01-01 Antipsychotic drugs5985, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56809]], camposKey:1137-4802 2005-01-01 "¡Dios te bendiga!": utopía y anamnesis en Casablanca3155, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3383]], camposKey:0378-6080 2004-01-01 Antipsychotic drugs4971, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3384]], camposKey:0031-6970 2004-01-01 Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study439444, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56802]], camposKey:1137-4802 2004-01-01 La construcción de la diferencia sexual en la fiesta de los toros1338, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40040]], camposKey:0114-5916 2004-01-01 Suicidal attempts in yellow cards reported to the Spanish pharmacovigilance system966966, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3385]], camposKey:0378-6080 2003-01-01 Antipsychotic drugs5369, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3386]], camposKey:0378-6080 2002-01-01 Antipsychotic drugs5377, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56800]], camposKey:1137-4802 2002-01-01 Tauromaquia o cómo plantarle cara al Horror3144, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=11193]], camposKey:0378-6080 2001-01-01 Antipsychotic drugs5381, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56799]], camposKey:1137-4802 2001-01-01 Consideraciones en torno al fantasma00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3388]], camposKey:0378-6080 2000-01-01 Antipsychotic drugs4882, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40051]], camposKey:0022-5347 2000-01-01 Doxazosin and priapism238238, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56803]], camposKey:1137-4802 2000-01-01 Historia (de España "e intrahistoria" del Sujeto): de Unamuno a Erice00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40038]], camposKey:1173-2563 2000-01-01 Utilisation of lipid-lowering drugs in Spain between 1986 and 1998197201, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3387]], camposKey:0960-1643 2000-01-01 Withdrawal syndrome after long-term treatment with tramadol406406, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3391]], camposKey:0378-6080 1999-01-01 Antipsychotic drugs4580, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3392]], camposKey:0025-7753 1999-01-01 Clinical trials do not guarantee the safety of the medicines. The case of the anorexiants fenfluramine and dexfenfluramine El ensayo clinico no garantiza la seguridad de los medicamentos. A proposito del caso de la fenfluramina y dexfenfluramina598598, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78269]], camposKey:0025-7753 1999-01-01 El consumo de analgésicos opiáceos en España: el papel de la codeína237238, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56798]], camposKey:1137-4802 1999-01-01 La teoría del texto y el porqué de la guerra2149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3390]], camposKey:0031-6970 1999-01-01 Opioid consumption in Spain - The significance of a regulatory measure681683, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3393]], camposKey:0025-7753 1999-01-01 The consumption of opioid analgesics in Spain. The role of codein El consumo de analgesicos opiaceos en Espana. El papel de la codeina237238, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56797]], camposKey:1137-4802 1999-01-01 Un perro andaluz: lectura y diferencia sexual3149, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3394]], camposKey:0378-6080 1998-01-01 Antipsychotic drugs4265, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56793]], camposKey:1137-4802 1998-01-01 La ciudad de los niños143146, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3395]], camposKey:0031-6970 1998-01-01 Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system483488, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3396]], camposKey:0378-6080 1997-01-01 Antipsychotic drugs3657, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78267]], camposKey:0025-7753 1997-01-01 Cambios en el patrón de consumo de analgésicos opioides en España281283, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40041]], camposKey:0025-7753 1997-01-01 Changes in the pattern of analgesic opioid drugs consumption in Spain281283, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56796]], camposKey:1137-4802 1997-01-01 Coyunturas. Manifiesto comunista6576, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3398]], camposKey:0306-5251 1997-01-01 Is metronidazole teratogenic? A meta-analysis179182, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=78266]], camposKey:0025-7753 1997-01-01 Terbinafina y hepatitis colestásica3560, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3397]], camposKey:0025-7753 1997-01-01 Terbinafine and cholestatic hepatitis Terbinafina y hepatitis colestásica.356356, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56791]], camposKey:1137-4802 1997-01-01 Tres al cuatro, un camino compartido: [reseña de la revista "Tres al cuatro"]154155, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40052]], camposKey:0379-0355 1996-11-01 Changes in opioid consumption patterns in Spain5858, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3402]], camposKey:0895-4356 1996-01-01 Aspirin or acetaminophen? A comparison from data collected by the Spanish Drug Monitoring System255261, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3403]], camposKey:0025-7753 1996-01-01 Metrorrhage produced by the topical application of medroxyprogesterone. Is it worth it? METRORRAGIAS PRODUCIDAS POR LA APLICACION TOPICA DE MEDROXIPROGESTERONA. MERECEN LA PENA?356356, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3401]], camposKey:0213-9111 1996-01-01 Pharmacologic surveillance and public health surveillance Farmacovigilancia y vigilancia de salud pública.152153, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3399]], camposKey:0214-4840 1996-01-01 Self-medication and addictive drug consumption among university students. Is there any relationship? Automedicacion y consumo de drogas en estudiantes universitarios. Existe alguna relacion?441446, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3400]], camposKey:0025-7753 1996-01-01 The DTP vaccine and the infant sudden death syndrome. Meta-analysis Vacuna DTP y síndrome de muerte súbita del lactante. Un metaanálisis649652, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56792]], camposKey:1137-4802 1996-01-01 The quiet man: sujeto y texto fílmico clásico20, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40050]], camposKey:0114-5916 1995-01-01 ACE Inhibitors and Impotence: A Case Series from the Spanish Drug Monitoring System130131, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40054]], camposKey:0144-1795 1995-01-01 Age-related changes in contractile responses to noradrenaline in isolated blood vessels from rat and rabbit321326, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3404]], camposKey:0378-6080 1995-01-01 Antipsychotic drugs4060, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56688]], camposKey:1053-8569 1995-01-01 Aspirin and paracetamol: Changing pattern of use in Spain381382, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40055]], camposKey:0306-5251 1995-01-01 Before and after triazolam: changes in the consumption ofhypnotics in Spain289290, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3405]], camposKey:0212-6567 1995-01-01 Gynaecomastia produced by nifedipine GINECOMASTIA PRODUCIDA POR NIFEDIPINO115116, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=40047]], camposKey:0002-9270 1995-01-01 Gynecomastia and sexual disorders after the administration of omeprazole10281029, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56805]], camposKey:0214-462X 1995-01-01 La violencia y la televisión: repercusiones de la cultura audiovisual postmoderna163176, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56813]], camposKey:1132-7871 1994-01-01 Criterios de periodización del cine: A propósito de Georges Méliès ¿Es posible otra historia del cine?: Una historia linealista y antropomórfica; Del relativismo cultural al political correct; Noël Burch y el MRI; Georges Méliès y el cine "primitivo".926, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56807]], camposKey:0214-462X 1994-01-01 La prehistoria de la televisión en el cine primitivo. Análisis de "Long Distance Wireless Photography" (Georges Méliès, 1908)2134, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56815]], camposKey:0214-6606 1993-01-01 Efectos de verdad: texto y discurso en el cine clásico3547, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3406]], camposKey:0025-7753 1993-01-01 Neurologic alterations due to diclofenac [2] ALTERACIONES NEUROLOGICAS DEBIDAS A DICLOFENACO [2]7677, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3408]], camposKey:0014-2565 1992-01-01 Galactorrhoea in a woman treated with theophylline [1] COMUNICACION DE UN CASO DE GALACTORREA EN PACIENTE TRATADA CON TEOFILINA [1]4849, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3409]], camposKey:0014-2565 1992-01-01 Hypoglycemia secondary to tenoxicam [1] HIPOGLUCEMIA SECUNDARIA A TENOXICAM [1]5051, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3407]], camposKey:0025-7753 1992-01-01 The increase of the number of absences following exposition to amoxycillin/clavulanic acid [2] AUMENTO DEL NUMERO DE AUSENCIAS TRAS LA EXPOSICION A AMOXICILINA/ACIDO CLAVULANICO [2]793794, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56808]], camposKey:0214-462X 1991-01-01 Notas para una redefinición de la teoría del cine151164, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3410]], camposKey:0025-7753 1991-01-01 Somnolence during diosmine therapy SOMNOLENCIA EN EL CURSO DE UN TRATAMIENTO CON DIOSMINA198199, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3411]], camposKey:0212-6567 1990-01-01 Gum hypertrophy induced by nifedipine HIPERPLASIA GINGIVAL PRODUCIDA POR NIFEDIPINA160161, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56820]], camposKey:0214-6606 1990-01-01 Una minuciosa y cuidada revisión de una parcela del cine español129131, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56806]], camposKey:0214-462X 1989-01-01 Apuntes sobre algunos problemas teóricos del análisis textual fílmico6573, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=56821]], camposKey:0214-6606 1989-01-01 Lacan / Hitchcock171172, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3413]], camposKey:0025-7753 1985-01-01 Declaration of tuberculosis and consumption of tuberculostatics in the provinces of Leon and Valladolid Declaración de tuberculosis y consumo de tuberculostáticos en las provincias de León y Valladolid.758759, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3412]], camposKey:0025-7753 1985-01-01 Trends in drug utilization in Valladolid and the province Evolución del consumo de medicamentos en Valladolid y provincia.758758, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=3414]], camposKey:0025-7753 1984-01-01 Drug consumption in Valladolid and its province Estudio sobre el consumo de medicamentos en Valladolid y provincia.472473][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=21501]},camposKey: 9 0 La gestión de la huella fotográfica y fílmica de lo real como documento del pasado 8492987618La historia a través de los Mass Media 1 null Creaciones Vicent Gabrielle , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=26785]},camposKey: 171 174 El antiapocalipsis, según Lars van Trier 8484488292Estudios de Historia y Estética del cine: 50 Aniversario de la Cátedra de Cine de la Universidad de Valladolid 1 2015-01-01 Ediciones Universidad de Valladolid (EdUVa) , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=21503]},camposKey: 111 128 La Cámara pulsional 8484485463Caleidoscopio cinematográfico 1 2010-01-01 Secretariado de Publicaciones , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=24031]},camposKey: 0 0 Entre la ideología y el conocimiento 8484583074La Representació de gènere a la publicitat del segle XXI 1 2009-01-01 Servei de Publicacions , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=21502]},camposKey: 13 46 ¿Inventaron el cine los hermanos Lumière? 8484484580Siete miradas, una misma luz 1 2008-01-01 Secretariado de Publicaciones , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=21505]},camposKey: 51 62 La construcción de la ciudad moderna en el Wester: El hombre que mató a Liberty Valance 84-95211-73-4Imágenes de la ciudad 1 2003-01-01 Universidad de Burgos , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=21504]},camposKey: 131 148 Reflexiones teóricas en torno al cinematógrafo en Valladolid 8460561089Primeros tiempos del cinematógrafo en España 1 1996-01-01 Universidad de Oviedo ][][Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=116802],camposKey=978-84-16822-00-3Contrapolítica: manual de resistencia 1 2016-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=116803],camposKey=978-84-95917-72-0El cine de Clint Eastwood: un análisis textual 1 2011-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=116801],camposKey=978-84-96186-51-4En los orígenes del cine 1 2009-01-01 }, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=120417],camposKey=8445805304Diccionario de farmacoepidemiología 1 1997-01-01 Masson}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=116804],camposKey=84-87739-64-4El cine como experiencia estética 1 1997-01-01 Caja España}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=116776],camposKey=8445805304Diccionario de farmacoepidemiología 1 1996-01-01 Masson}, Llibres{id=com.sigma.fs3.argos.domain.gpc.GpcLlibresPK[ifcactivitat=LLI, ifccomptador=101541],camposKey=84-7762-450-XEl consumo de medicamentos en España 1 1994-01-01 }][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62764]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62764]]][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=541]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30540]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30354]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145636030]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30057]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145635367]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145637536]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145629719]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145632512]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145629904]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145628951]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145625472]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145632184]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=2145627844]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2f322ec0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@202fb4d6, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1b2ab0c5, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@47e81e32, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@79127c21, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@2446eed1, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6aa4de04, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6dba44ec, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@723ce0e, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@1400985d, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@58183027, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@673a82ec, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7e7073bb, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6ea2de58, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@77a252a3, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@44bc9359, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@392cddde, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@418494bd][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@5d3df7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@38a9d9, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3894e4, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3751f7, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37503d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373a77, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373595, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373a6e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dfdb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373489, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3731d2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37326b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3732ea, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372f73, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373394, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372fe0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3729ec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dc68, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dc69, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3734ec, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372e19, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d971, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63d972, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372f3c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372c45, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63de94, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63de95, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372b98, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372cd1, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63dc10, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372e79, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372bfb, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@63da5c, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ae0, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372adf, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373000, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373004, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3720df, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3729b8, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372ad6, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372a0b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3720de, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@37224b, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@372522, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b8f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373d14, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b6f, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373b8e, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@373e47][][][][][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@414ec8], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413366], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41315d], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4131d9], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413c1e], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@413fb7], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@4121e3], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@41208f], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@460459], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f403], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@45f37f]][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@135a8, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@147eb, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1399c][]
